Variant report
Variant | esv3419208 |
---|---|
Chromosome Location | chr10:56351995-56372121 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:32)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 2)
- miRNA target sites (count:0)
(count:32 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr10:56354640-56354790 | HepG2 | liver: | n/a | n/a |
2 | CTCF | chr10:56365480-56365630 | GM12864 | blood: | n/a | n/a |
3 | CTCF | chr10:56358460-56358493 | GM10248 | blood: | n/a | n/a |
4 | EBF1 | chr10:56367734-56368066 | GM12878 | blood: | n/a | chr10:56367900-56367913 chr10:56367901-56367912 chr10:56367902-56367911 |
5 | FAM48A | chr10:56365261-56365409 | GM12878 | blood: | n/a | n/a |
6 | GATA2 | chr10:56365914-56366691 | HUVEC | blood vessel: | n/a | n/a |
7 | GATA3 | chr10:56365251-56365446 | SH-SY5Y | brain: | n/a | n/a |
8 | GATA3 | chr10:56363804-56364057 | SH-SY5Y | brain: | n/a | n/a |
9 | GATA3 | chr10:56366654-56366782 | SH-SY5Y | brain: | n/a | n/a |
10 | GTF2F1 | chr10:56367699-56367761 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | MAFK | chr10:56363067-56363187 | HepG2 | liver: | n/a | n/a |
12 | MAX | chr10:56354815-56354919 | NB4 | blood: | n/a | chr10:56354847-56354857 chr10:56354870-56354880 |
13 | MAZ | chr10:56354795-56354858 | HepG2 | liver: | n/a | n/a |
14 | NANOG | chr10:56367842-56368152 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | POLR2A | chr10:56354733-56354765 | A549 | lung: | n/a | n/a |
16 | POLR2A | chr10:56354460-56354517 | A549 | lung: | n/a | n/a |
17 | POLR2A | chr10:56354506-56354532 | Gliobla | brain: | n/a | n/a |
18 | POLR2A | chr10:56358300-56358308 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr10:56356096-56356296 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr10:56367505-56367732 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | POLR2A | chr10:56354418-56354446 | Gliobla | brain: | n/a | n/a |
22 | POLR2A | chr10:56354335-56354349 | Gliobla | brain: | n/a | n/a |
23 | RFX5 | chr10:56371239-56371247 | K562 | blood: | n/a | n/a |
24 | SETDB1 | chr10:56356123-56356795 | U2OS | brain: | n/a | n/a |
25 | SPI1 | chr10:56359573-56359874 | HL-60 | blood: | n/a | n/a |
26 | STAT3 | chr10:56370195-56370470 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | TAF7 | chr10:56367422-56367828 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | TBP | chr10:56367598-56367937 | H1-hESC | embryonic stem cell: | n/a | n/a |
29 | TCF12 | chr10:56367788-56368093 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | TCF12 | chr10:56367798-56368054 | H1-hESC | embryonic stem cell: | n/a | n/a |
31 | TCF7L2 | chr10:56369218-56369675 | HEK293 | kidney: | n/a | chr10:56369332-56369342 |
32 | WRNIP1 | chr10:56365458-56365710 | GM12878 | blood: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MTRNR2L5-4 | chr10:56365452-56366745 | NONHSAT013457 |
2 | lnc-MTRNR2L5-4 | chr10:56365452-56366745 | ENSG00000234173.1 |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-548f-5p | chr10:56367686-56367707 | MIMAT0026739 |
hsa-miR-548f-3p | chr10:56367649-56367667 | MIMAT0005895 |
No data |
Variant related genes | Relation type |
---|---|
NEFMP1 | TF binding region |
MIR548F1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367736023 | chr10:56354230-56354231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150783802 | chr10:56354236-56354237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139139371 | chr10:56354253-56354254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547282482 | chr10:56354264-56354265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540044850 | chr10:56354266-56354267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558416373 | chr10:56354291-56354292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538801119 | chr10:56354301-56354302 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs112964866 | chr10:56354313-56354314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575740626 | chr10:56354332-56354333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529429602 | chr10:56354342-56354343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538223913 | chr10:56354360-56354361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs554977191 | chr10:56354364-56354365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1937407 | chr10:56354383-56354384 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs115615872 | chr10:56354384-56354385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560524945 | chr10:56354403-56354404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145116417 | chr10:56354404-56354405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545620781 | chr10:56354424-56354425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs117146140 | chr10:56354461-56354462 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs142225164 | chr10:56354487-56354488 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs182133037 | chr10:56354488-56354489 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs372276735 | chr10:56354498-56354499 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs144213925 | chr10:56354502-56354503 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs185928032 | chr10:56354527-56354528 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs541496427 | chr10:56354528-56354529 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs559825090 | chr10:56354534-56354535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547664358 | chr10:56354535-56354536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116110741 | chr10:56354539-56354540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539600824 | chr10:56354555-56354556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552729882 | chr10:56354583-56354584 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532877578 | chr10:56354725-56354726 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs569398668 | chr10:56354743-56354744 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs190846275 | chr10:56354747-56354748 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs555013985 | chr10:56354764-56354765 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs11492307 | chr10:56354771-56354772 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs12244151 | chr10:56354806-56354807 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs147769450 | chr10:56354810-56354811 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs35655891 | chr10:56354837-56354838 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs12265998 | chr10:56354890-56354891 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs570709002 | chr10:56356134-56356135 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs539789208 | chr10:56356165-56356166 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs556428816 | chr10:56356234-56356235 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs2154267 | chr10:56356273-56356274 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs535628165 | chr10:56356276-56356277 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs183937124 | chr10:56356324-56356325 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs140557666 | chr10:56356325-56356326 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs150447980 | chr10:56356337-56356338 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs187751701 | chr10:56356350-56356351 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs557739638 | chr10:56356393-56356394 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs12246636 | chr10:56356437-56356438 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs192422504 | chr10:56356454-56356455 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Melanoma | 17363583 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56354200-56354600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr10:56364600-56367600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr10:56365600-56366800 | Enhancers | HUVEC | blood vessel |
4 | chr10:56366800-56371200 | Weak transcription | HUVEC | blood vessel |
5 | chr10:56367000-56367800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr10:56367200-56368400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr10:56367600-56368000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr10:56367600-56368200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr10:56367600-56369200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr10:56368600-56368800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr10:56371200-56372800 | Enhancers | HUVEC | blood vessel |